1232 related articles for article (PubMed ID: 26858290)
1. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
Austin PC; Lee DS; Fine JP
Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
[TBL] [Abstract][Full Text] [Related]
2. [A new perspective of survival data on clinical epidemiology: introduction of competitive risk model].
Nie ZQ; Ou YQ; Qu YJ; Yuan HY; Liu XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1127-1131. PubMed ID: 28847068
[TBL] [Abstract][Full Text] [Related]
3. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
4. Cumulative incidence in competing risks data and competing risks regression analysis.
Kim HT
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
[TBL] [Abstract][Full Text] [Related]
5. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
[TBL] [Abstract][Full Text] [Related]
6. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
[TBL] [Abstract][Full Text] [Related]
7. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.
Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S
Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831
[TBL] [Abstract][Full Text] [Related]
8. A note on competing risks in survival data analysis.
Satagopan JM; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach AD
Br J Cancer; 2004 Oct; 91(7):1229-35. PubMed ID: 15305188
[TBL] [Abstract][Full Text] [Related]
9. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
Austin PC; Fine JP
Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
[TBL] [Abstract][Full Text] [Related]
10. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
Nolan EK; Chen HY
Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
[TBL] [Abstract][Full Text] [Related]
12. Competing risk bias in Kaplan-Meier risk estimates can be corrected.
van Walraven C; Hawken S
J Clin Epidemiol; 2016 Feb; 70():101-5. PubMed ID: 26327491
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.
Austin PC; Putter H; Lee DS; Steyerberg EW
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008368. PubMed ID: 35098725
[TBL] [Abstract][Full Text] [Related]
14. [An introduction to competing risks analysis].
Pintilie M
Rev Esp Cardiol; 2011 Jul; 64(7):599-605. PubMed ID: 21621892
[TBL] [Abstract][Full Text] [Related]
15. Model selection in competing risks regression.
Kuk D; Varadhan R
Stat Med; 2013 Aug; 32(18):3077-88. PubMed ID: 23436643
[TBL] [Abstract][Full Text] [Related]
16. Transplant as a competing risk in the analysis of dialysis patients.
van Geloven N; le Cessie S; Dekker FW; Putter H
Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii53-ii59. PubMed ID: 28340227
[TBL] [Abstract][Full Text] [Related]
17. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
[TBL] [Abstract][Full Text] [Related]
18. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
Rosthøj S; Andersen PK; Abildstrom SZ
Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
20. Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
Zhu X; Kranse R; Bul M; Bangma CH; Schröder FH; Roobol MJ
Can J Urol; 2013 Jun; 20(3):6756-60. PubMed ID: 23783043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
